Wall Street has differing views on the prospects of three stocks set to go public in 2026. Trade Desk (TTD) rebounded 24.38% to $29.79, but is still down 55.23% year-over-year. Despite strong performance in the fourth quarter, concerns about slowing growth remain, with a conservative consensus target price of $31.89. Moderna (MRNA) soared 82.54% to $53.83, about 20% higher than the analyst consensus target of $42.90. Strategy (MSTR) rebounded to $139.81, with a bullish consensus target price of $394.38, implying an 182% upside, which is directly related to its holding of 713,502 Bitcoin.

BTC-1,57%
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
0/400
No comments
  • Pin